1 Cannabis Stock That Could Still Make You Rich

With a share price below $1, there isn’t anywhere for Aleafia Health Inc. (TSX:ALEF) to go but up.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are many cannabis companies out there going through a pretty significant setback at the moment. While some cannabis companies are posting their first profits, others are posting more and more losses. While I’m a believer that if you’re investing in a larger company, these are merely growing pains, there are still a few cannabis companies out there that offer investors away to make significant returns within a short period of time.

One such company is Aleafia Health (TSX:ALEF). Looking at its share price, Aleafia offers investors an incredibly cheap way to get in on the cannabis industry. But this company offers a lot more than a cheap share price. Most recently, the company posted quarterly results that had investors drooling. The company had major revenue growth in the quarter, leading management to believe by the next quarter the company will actually be able to post a profit for the first time.

That’s revenue growth came from two sources. First of all, there was an increase in recurring revenue from patients needing medicinal marijuana both at home and abroad in Australia. A lot of this came from the company’s acquisition of Emblem, a medicinal marijuana provider that gave Aleafia access to a number of countries it did not have prior to the acquisition. It led the company to its largest sale yet at $1,000,000, and access to 138,000 kilograms of marijuana per year.

Then there was the incredible increase in its production capacity. The cannabis company quadrupled the size of its Port Perry Outdoor Grow Facility to 1.1 million square feet of cultivation space. The new space cost about $1.2 million, and with $58 million in cash on hand, this proved to be a minor hurdle. Between the acquisition of Emblem and this major increase in production, Aleafia has likely shot itself up into the top 10 marijuana producers in the country.

So, while analysts predicted the company wouldn’t be posting a profit until sometime in 2020, this news has sent that prediction much closer in time. While it’s true that a significant jump might still be on the horizon given that the cannabis industry is down and a recession is looming closer, I would still consider now a great opportunity to buy even a small stake of this stock.

In fact, with a share price below $1, that leaves very few ways for the share price to go but up over the next few months to a year. Over the next 12 months, analysts predict the stock could even triple to $3 per share. With a share price at $0.92 as of writing, that means a $5,000 investment would be worth $16,305 in only a year!

Not to say that bet isn’t without risk, as again this stock is part of the risky cannabis industry. However, as I mentioned, I don’t see Aleafia going much lower, and neither do many analysts. So, with that in mind, this could be an easy way to turn rags to riches for investors willing to do some extra research and hold their breath for the next 12 months.

Should you invest $1,000 in Aleafia Health Inc. right now?

Before you buy stock in Aleafia Health Inc., consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Aleafia Health Inc. wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $19,624.59!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 34 percentage points since 2013*.

See the Top Stocks * Returns as of 11/20/24

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned.

If You Thought Apple and Microsoft Were Big, You Need to Read This.

The steel industry produced the world's first $1 billion company in 1901, and it wasn't until 117 years later that technology giant Apple became the first-ever company to reach a $1 trillion valuation.

But what if I told you artificial intelligence (AI) is about to accelerate the pace of value creation? AI has the potential to produce several trillion-dollar companies in the future, and The Motley Fool is watching one very closely right now.

Don't fumble this potential wealth-building opportunity by navigating it alone. The Motley Fool has a proven track record of picking revolutionary growth stocks early, from Netflix to Amazon, so become a premium member today.

See the 'AI Supercycle' Stock

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Could Aurora Cannabis Stock Finally Recover by Year-End?

Down 99% from all-time highs, Aurora Cannabis stock is focused on improving profit margins and expanding sales of its medical…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Are Pot Stocks About to Surge Again? 

With pot stocks making big moves of late, many investors are now asking whether the cannabis sector is worth investing…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Pot Stocks Aurora Cannabis and Canopy Growth Bounce Back in Q4?

Down over 99% from all-time highs, Canadian pot stocks such as Aurora Cannabis and Canopy Growth remain high-risk bets.

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2024?

Down 98% from all-time highs, Canopy Growth remains a high-risk investment in 2024 given its weak fundamentals.

Read more »

Tech Stocks

3 No-Brainer Stocks to Buy With $20 Right Now

These three stocks are easy buys for those who don't have all that much to spend, and want long-term growth…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Slow Burn: Is Aurora Cannabis Finally a Good Buy in June?

One of the benefits of choosing from some of the most beaten-down market segments like cannabis is that even a…

Read more »